Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

125
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Mechanistic Association Between Intestinal Permeability and the Gut Microbiome in Cirrhosis: Role of Phascolarctobacterium.

United European gastroenterology journal·2026
Same author

Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPD.

Biomarker research·2026
Same author

Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis.

The Journal of clinical endocrinology and metabolism·2026
Same author

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same author

Homocysteine and S-adenosyl-L-homocysteine impair development and methylation in yeast and flies.

Disease models & mechanisms·2026
Same author

Enhanced fatty acid availability rewires fibroblasts metabolism and decreases collagen deposition in lung fibrosis.

Cellular and molecular life sciences : CMLS·2026

Related Experiment Video

Updated: May 12, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.8K

The Acrolein-Lipopolysaccharide Mouse Model for Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.

Bernhard Fe Reiter1,2, Natalie Bordag1,3, Diana Schnoegl1

  • 1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.

American Journal of Respiratory Cell and Molecular Biology
|May 9, 2025
PubMed
Summary

A new mouse model for chronic obstructive pulmonary disease (COPD) uses lipopolysaccharide (LPS) and acrolein (Acro) for faster, more representative disease study. This model reveals key inflammatory and metabolic changes, aiding COPD research.

Keywords:
COPDacroleininflammationlipopolysaccharidemouse model

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

24.7K
Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice
04:10

Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice

Published on: March 31, 2023

4.1K

Related Experiment Videos

Last Updated: May 12, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.8K
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

24.7K
Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice
04:10

Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice

Published on: March 31, 2023

4.1K

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Metabolomics

Background:

  • Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with limited pre-clinical models.
  • Existing models like smoke or elastase have drawbacks, including long durations and insufficient pathophysiological detail.

Purpose of the Study:

  • To develop a novel, time-efficient mouse model for studying COPD.
  • To investigate the immunological and metabolomic changes induced by this new model.

Main Methods:

  • Mice were treated weekly for four weeks with bacterial lipopolysaccharide (LPS) and acrolein (Acro).
  • Histological analysis, multicolour flow cytometry, and nuclear magnetic resonance (NMR) were used to assess changes.
  • Dexamethasone was used to evaluate therapeutic intervention.

Main Results:

  • Acro/LPS treatment induced moderate airspace enlargement and bronchial remodelling.
  • Significant increases in macrophages, T-helper cells, and specific cytokines (CXCL11, IL-17a, TNF-α) were observed.
  • Metabolomic analysis revealed elevated COPD-associated metabolites and altered energy metabolism.

Conclusions:

  • The Acro/LPS mouse model is a practical, representative, and time-efficient tool for COPD research.
  • This model allows for the study of COPD's immunological and pathophysiological development.
  • Dexamethasone intervention demonstrated potential therapeutic effects on inflammation and histology.